FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)

View source ↗

Summary

FDA approved a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine hydrochloride) under ANDA076447, filed by American Sales Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• CAREONE ALLERGY RELIEF (FEXOFENADINE HCL)

Snippet

SUPPL AP for CAREONE ALLERGY RELIEF (FEXOFENADINE HCL)